Courtesy of Benzinga.
Shares of Sarepta Therapeutics Inc (NASDAQ: SRPT) are in play on Monday amid consolidation announcements within the sector.
On Monday, BioMarin Pharmaceutical Inc. announced the company will acquire Prosensa Holding NV for roughly $680 million.
On the heels on the announcement, shares of Sarepta were up 10 percent.
Posted-In: News M&A Pre-Market Outlook